Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Cancer Research|October 18, 2002
Integrated functional genomics approach for the design of patient-individual antitumor vaccinesToni Weinschenk, Cécile Gouttefangeas, Markus Schirle, et al.
Cancer Research|February 12, 2004
Induction of adipophilin-specific cytotoxic T lymphocytes using a novel HLA-A2-binding peptide that mediates tumor cell lysisSusanne M Schmidt, Kerstin Schag, Martin R Müller, et al.
Oncoimmunology|January 9, 2018
Antigenic expression and spontaneous immune responses support the use of a selected peptide set from the IMA950 glioblastoma vaccine for immunotherapy of grade II and III gliomaValérie Dutoit, Denis Migliorini, Giulia Ranzanici, et al.
Nature|November 28, 2014
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencingMahesh Yadav, Suchit Jhunjhunwala, Qui T Phung, et al.
Proteomics|March 6, 2018
Translating Immunopeptidomics to Immunotherapy-Decision-Making for Patient and Personalized Target SelectionJens Fritsche, Barbara Rakitsch, Franziska Hoffgaard, et al.
Nature Immunology|February 25, 2003
An essential role for tripeptidyl peptidase in the generation of an MHC class I epitopeUlrike Seifert, Concepción Marañón, Ayelet Shmueli, et al.
Brain : a Journal of Neurology|March 16, 2012
Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapyValérie Dutoit, Christel Herold-Mende, Norbert Hilf, et al.
The Lancet. Oncology|October 11, 2016
IMA901, a multipeptide cancer vaccine, plus sunitinib versus sunitinib alone, as first-line therapy for advanced or metastatic renal cell carcinoma (IMPRINT): a multicentre, open-label, randomised, controlled, phase 3 trialBrian I Rini, Arnulf Stenzl, Romauld Zdrojowy, et al.
Immunological Reviews|October 14, 2017
Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillanceNorma Bloy, Pauline Garcia, Céline M Laumont, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2016
Targeting Carcinoembryonic Antigen with DNA Vaccination: On-Target Adverse Events Link with Immunologic and Clinical OutcomesKaty J McCann, Ann Mander, Angelica Cazaly, et al.
Pageof 4